Compound’s mezzanine financing model of Team, Inc.’s second lien term loan gives an investor who buys at par of the September 30, 2026 accreted balance a 17.6% IRR and 1.82x to the June 10, 2030 maturity. The loan pays all of its interest in kind in every quarter of the projection, so $70.3 million accretes to $118.7 million. Called on December 31, 2026, it returns 33.7% on 1.08x. Of the three flags in the request, only the downside recovery trips: 0% of the $83.8 million accreted balance.
Two readings set those numbers. The 17.6% includes an 8% Applicable Premium paid at maturity, because Compound reads the agreement’s trigger, a principal payment “for any reason”, literally. Without it the IRR is 15.2%. The 0% recovery comes from a default on December 31, 2027 at 5.0x an EBITDA 25% below plan, about half the 9.8x at which the market values the company today. These are the model’s results under its assumptions, not a view on Team’s credit or on where the loan trades.
You provide junior capital. On a deal you need the PIK balance accreting, the value of the equity attached, the return at each date the borrower can call you, where you sit against the senior debt, and what you recover if the company fails. We asked Compound to build that model on a real deal from public filings. It ran on November 19, 2026 and returned one Excel workbook of eight sheets and a short written answer.
What the workbook shows:
- The security. Second lien term loans from funds managed by Corre Partners, at 13.75% on $70.3 million at September 30, 2026, stepping up to a 14.5% cap, all PIK while first lien net leverage is 3.50x or more.
- The returns. 17.6% and 1.82x to maturity on the loan alone, 16.3% and 1.73x counting the warrants at their fair value cost, and 33.7% on 1.08x if called at the end of 2026.
- The warrants. 500,000 at a $15.00 strike, worth $6.6 million under Black-Scholes at the $24.79 close and 58.3% realized volatility.
- The credit. 6.21x leverage through the second lien on last-twelve-month Adjusted EBITDA of $52.6 million, 7.80x through the Series B preferred below it, and 2.22x cash interest coverage.
- The downside. $280.5 million of claims ahead of the second lien against $209.5 million of value at 5.0x stressed EBITDA. The second lien needs 6.7x to recover its first dollar.
The terms come from Team’s filings on SEC EDGAR: the 8-K of March 13, 2025 and its Exhibit 10.2, the 8-K of September 15, 2025, the 10-K for fiscal 2025 and the 10-Q for the quarter ended September 30, 2026. Adjusted EBITDA and guidance come from two earnings releases. Share prices are from Compound’s daily closing prices, the risk-free rate from the Treasury par yield curve and senior floating rates from the SOFR forward curve, all of November 19, 2026. No input needed a web search. Every other input is marked “Analyst assumption” with a reason.
“I provide junior capital and want a mezzanine or holdco PIK financing model built on a real deal. From SEC EDGAR, pick one U.S. public company that in the last 24 months issued second-lien notes, mezzanine debt, holdco PIK notes or preferred equity to a private credit fund, with the terms in an 8-K or an exhibit: cash and PIK interest, warrants or other equity, call protection and maturity. Build the security's cash flows with the PIK balance accreting each period, the warrant value from the company's share price and volatility, and the investor's IRR and multiple of money to maturity and at each call date with the make-whole or call premium. Show leverage through the security from the latest filings, interest coverage on cash interest, the intercreditor position against the senior debt, and the investor's recovery in a downside at a distressed multiple. Add a sensitivity table of IRR to the exit date and the share price at exit. Flag cash interest coverage below 1.5x, leverage through the security above 7.0x, and a downside recovery below 50% of the accreted balance. Use the stored public data wherever it has the figure, and web search only for what it lacks. Put every input on an Assumptions sheet with one column that says where it came from: a cited source, or "analyst assumption" for a figure I would set myself, with the reason for the value you chose. Every output must be a live formula that traces back to the Assumptions sheet. Add a Sources sheet listing each data source, what it gave and its date. Deliver one Excel workbook and a short summary of the result, the flags, and what I would need from the company to firm it up. Cite every sourced figure.”
That is the request as we sent it, without its closing line, which asks that no name or email be put in the workbook.
Choosing the deal: Team’s second lien from Corre Partners funds
Compound chose Team, Inc. (NYSE: TISI), a specialty industrial inspection, heat-treating and mechanical services company, and the second lien term loans held by funds managed by Corre Partners Management. The 8-K of March 13, 2025 and its Exhibit 10.2 give every term the request asked for: cash and PIK interest, call protection, maturity and the lien ranking.
The 8-K describes a $107.4 million second lien term loan from Corre Partners and its affiliates: $97.4 million funded at closing on March 12, 2025 and a $10.0 million delayed draw whose window closed on April 15, 2026. The loans mature on June 10, 2030.
The request asked for a security sold to a private credit fund, and Compound’s answer is careful on the point. On Form ADV, Corre’s funds are reported as hedge fund and private equity fund types, and “Form ADV has no ‘private credit’ category.” The loan itself is privately placed second lien debt.
The equity is older than the loan. Corre holds 500,000 warrants at a $15.00 strike, expiring on December 8, 2028, which the answer notes “were issued in 2021 with Corre’s earlier loan, not with the 2025 deal.” The model values them as part of the position because the lender holds both.
The 10-Q reports $70.3 million outstanding at September 30, 2026, below the $97.4 million funded at closing, with all 2026 interest paid in kind. The workbook takes the 10-Q balance as the entry point and does not walk from one figure to the other.
The coupon, the step-ups and the leverage PIK toggle
The coupon started at 13.5%, steps up 0.25% a quarter from September 30, 2026 while principal exceeds $48.0 million, and caps at 14.5%. Interest is all PIK while first lien net leverage is 3.50x or more. The model’s leverage proxy starts at 4.53x and never falls below 3.50x, so the loan pays no cash interest before maturity.
| B | C | E | |
|---|---|---|---|
| 5 | Input | Value | Source / basis |
| 9 | Original principal, 2025 Second Lien Term Loans | 97,413 | Team 8-K filed 2025-03-13, Item 1.01 |
| 11 | Maturity date | 6/10/2030 | Team 8-K filed 2025-03-13, Item 1.01 |
| 13 | Base interest rate | 13.50% | Team 8-K filed 2025-03-13, Item 1.01 |
| 14 | Quarterly rate step-up while balance exceeds threshold | 0.25% | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), Sec. 4.1(a) |
| 15 | Maximum interest rate | 14.50% | Team 8-K filed 2025-03-13, Item 1.01 |
| 16 | Step-up test: principal balance threshold | 47,968 | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), Sec. 4.1(a) |
| 18 | Interest rate in effect at 2026-09-30 (after first step-up) | 13.75% | Team 10-Q for quarter ended 2026-09-30 (filed 2026-11-12), Note 10 |
| 20 | All-PIK test: First Lien Net Leverage at or above | 3.50x | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), Sec. 4.1(b) |
| 21 | All-cash test: First Lien Net Leverage at or below | 3.00x | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), Sec. 4.1(b) |
| 22 | PIK share of interest between the two tests | 50% | Team 8-K filed 2025-03-13, Item 1.01 |
| 26 | Applicable Premium: through 1st anniversary of closing | 0.00% | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), 'Applicable Premium' |
| 27 | Applicable Premium: 1st to 2nd anniversary | 4.00% | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), 'Applicable Premium' |
| 28 | Applicable Premium: after 2nd anniversary | 8.00% | Team 8-K filed 2025-03-13, Ex. 10.2 (Second A&R Second Lien Term Loan Credit Agreement, 2025-03-12), 'Applicable Premium' |
| 29 | Premium also paid on scheduled amortization and at maturity (1 = yes, 0 = no) | 1 | Analyst assumption: the trigger is any payment of principal 'for any reason' (Ex. 10.2, 'Applicable Premium Trigger Event'); read literally, 8% is due at maturity. Set to 0 if counsel reads it as prepayment-only. |
Amortization follows the same leverage grid as the cash and PIK split: nothing at 3.50x or more, 0.25% of original principal a quarter at 3.00x or less. Each quarter’s split uses the ratio at the prior quarter end.
The model’s proxy for the ratio is the ABL and the first lien term loan, less unrestricted cash up to the agreement’s $15.0 million cap, over last-twelve-month Adjusted EBITDA. That gives 4.53x at September 30, 2026. The base case grows EBITDA from the low end of FY2026 guidance, $56.0 million, by 5% in 2027, 4% in 2028 and 3% a year after, and holds the ABL flat because free cash flow was negative in the first nine months of 2026. The ratio drifts down to 3.66x at the last test before maturity and never crosses 3.50x.
| B | D | E | F | G | H | I | L | P | Q | R | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | Period end date | 12/31/2026 | 3/31/2027 | 6/30/2027 | 9/30/2027 | 12/31/2027 | 3/31/2028 | 12/31/2028 | 12/31/2029 | 3/31/2030 | 6/10/2030 |
| 29 | Opening balance | 70,347 | 72,785 | 75,298 | 77,973 | 80,823 | 83,776 | 93,230 | 107,502 | 111,431 | 115,415 |
| 30 | Leverage test used (prior quarter-end, x) | 4.53x | 4.25x | 4.19x | 4.13x | 4.07x | 4.01x | 3.88x | 3.73x | 3.69x | 3.66x |
| 31 | PIK share of interest | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| 32 | Interest rate for the period | 13.75% | 14.00% | 14.25% | 14.50% | 14.50% | 14.50% | 14.50% | 14.50% | 14.50% | 14.50% |
| 33 | Interest accrued | 2,438 | 2,513 | 2,675 | 2,850 | 2,954 | 3,029 | 3,407 | 3,929 | 3,984 | 3,255 |
| 34 | PIK interest capitalized | 2,438 | 2,513 | 2,675 | 2,850 | 2,954 | 3,029 | 3,407 | 3,929 | 3,984 | 3,255 |
| 35 | Cash interest paid | - | - | - | - | - | - | - | - | - | - |
| 38 | Repayment at maturity | - | - | - | - | - | - | - | - | - | 118,670 |
| 39 | Closing balance ($000) | 72,785 | 75,298 | 77,973 | 80,823 | 83,776 | 86,805 | 96,638 | 111,431 | 115,415 | - |
| 41 | Applicable Premium if principal is paid on this date | 4% | 8% | 8% | 8% | 8% | 8% | 8% | 8% | 8% | 8% |
| 42 | Applicable Premium on scheduled principal | - | - | - | - | - | - | - | - | - | 9,494 |
The rate reaches its 14.5% cap in the quarter ending September 30, 2027, because the balance stays far above the step-up threshold. Interest compounds quarterly on the opening balance, actual/365, and $48.3 million of it is capitalized by maturity, a 68.7% increase in the balance (our arithmetic).
For the toggle to flip to half cash, Adjusted EBITDA would have to reach about $68.1 million on today’s first lien debt, 29.4% above the last twelve months (our arithmetic). The base case reaches $63.8 million by June 2030. The agreement’s own definitions sit in compliance certificates that are not public, the first item Compound asks the company for. The debt schedule page shows the same quarterly mechanics on senior debt.
The Applicable Premium at maturity: one definition, 2.4 points of IRR
The premium is 4% between the first and second anniversaries of closing and 8% after the second. Exhibit 10.2 triggers it on any payment of principal “for any reason”, and Compound reads that as including repayment at maturity. On that reading the investor collects $9.5 million on top of $118.7 million at maturity and earns 17.6%. Without it the IRR is 15.2% and the multiple 1.69x.
Most junior capital call protection is a prepayment premium that falls away with time. This one steps up, from nothing in the first year to 4% and then 8%, and its trigger is broad enough to reach a scheduled repayment. The Assumptions sheet gives the reasoning and the switch: “read literally, 8% is due at maturity. Set to 0 if counsel reads it as prepayment-only.”
The premium is 7.4% of the maturity proceeds (our arithmetic), and the difference between the two readings is 2.4 points of IRR and 0.13x of multiple (our arithmetic). On a call the reading changes nothing: a borrower who refinances after March 12, 2027 pays the 8% under either reading.
The answer asks the company to confirm “that the 8% premium is due at maturity and on acceleration.” The second half matters for the downside, where the model leaves the premium out of the claim: “the premium is triggered on acceleration, but its allowance in chapter 11 is contested; recovery is measured on accreted principal.” A holder underwriting to 17.6% is relying on a reading that its own recovery case declines to rely on.
Warrant value from the share price and realized volatility
Corre’s 500,000 warrants at $15.00 are worth $6.6 million under Black-Scholes: $13.19 a warrant, of which $9.79 is intrinsic value at the $24.79 close of November 19, 2026 and $3.40 is time value. Volatility is 58.3%, realized over the last 252 daily returns, and the rate is the 2-year Treasury at 4.76%.
| B | C | |
|---|---|---|
| 6 | Share price ($) | $24.79 |
| 7 | Exercise price ($) | $15.00 |
| 8 | Valuation date | 11/19/2026 |
| 9 | Expiration date | 12/8/2028 |
| 10 | Time to expiry (years) | 2.05 |
| 11 | Volatility, realized 1-year (annualized) | 58.3% |
| 12 | Risk-free rate, continuously compounded | 4.7% |
| 13 | Dividend yield | 0.0% |
| 14 | d1 | 1.133 |
| 15 | d2 | 0.298 |
| 16 | Value per warrant ($) | $13.19 |
| 17 | Intrinsic value per warrant ($) | $9.79 |
| 18 | Time value per warrant ($) | $3.40 |
| 19 | Warrants held (shares) | 500,000 |
| 20 | Warrant value, total ($000) | 6,596 |
| 21 | Warrant value, % of accreted principal | 9.4% |
| 22 | Delta, N(d1) | 0.87 |
The warrants are deep in the money, with a delta of 0.87, and worth 9.4% of the accreted principal, a real part of the position. The model counts their fair value as capital at risk at entry, because “the warrants are an existing holding”, which lowers the hold-to-maturity IRR from 17.6% to 16.3%.
| B | C | |
|---|---|---|
| 5 | Realized volatility, annualized | 58.3% |
| 6 | Daily log returns used | 252 |
| 7 | Mean daily log return | 0.176% |
One day carries much of the volatility: on August 11, 2026 the close went from $16.55 to $22.71. Without that one return, realized volatility would be 49.1% (our arithmetic). The lower figure would cut only time value; the intrinsic $9.79 stays.
The valuation is not adjusted for dilution. The Corre warrants alone are 10.9% of the 4,583,209 shares outstanding, and with the APSC Holdco II warrants at $15.00 and the Stellex Tranche A warrants at $23.00, the in-the-money warrants come to 43.3% of the share count (our arithmetic). A fully diluted capitalization table is the last item on Compound’s list for the company.
IRR and multiple at each call date
The earlier the borrower calls, the higher the IRR and the lower the multiple. A call on December 31, 2026 at the 4% premium returns 33.7% on 1.08x; on December 31, 2027 at 8%, 22.3% on 1.29x; held to maturity, 17.6% on 1.82x.
| B | C | D | E | L | M | N | O | P | |
|---|---|---|---|---|---|---|---|---|---|
| 26 | Exit date | Premium | Balance ($000) | Proceeds ($000) | IRR, loan | MOIC, loan | IRR + warrants | MOIC + warrants | Hold (years) |
| 27 | 12/31/2026 | 4% | 72,785 | 75,696 | 33.7% | 1.08x | 30.0% | 1.07x | 0.25 |
| 28 | 3/31/2027 | 8% | 75,298 | 81,321 | 33.7% | 1.16x | 29.8% | 1.14x | 0.50 |
| 29 | 6/30/2027 | 8% | 77,973 | 84,211 | 27.2% | 1.20x | 23.9% | 1.17x | 0.75 |
| 30 | 9/30/2027 | 8% | 80,823 | 87,288 | 24.1% | 1.24x | 21.1% | 1.21x | 1.00 |
| 31 | 12/31/2027 | 8% | 83,776 | 90,479 | 22.3% | 1.29x | 19.5% | 1.25x | 1.25 |
| 32 | 3/31/2028 | 8% | 86,805 | 93,749 | 21.1% | 1.33x | 18.4% | 1.29x | 1.50 |
| 33 | 6/30/2028 | 8% | 89,943 | 97,138 | 20.2% | 1.38x | 17.7% | 1.33x | 1.75 |
| 34 | 9/30/2028 | 8% | 93,230 | 100,689 | 19.6% | 1.43x | 17.2% | 1.37x | 2.00 |
| 35 | 12/31/2028 | 8% | 96,638 | 104,369 | 19.1% | 1.48x | 16.8% | 1.42x | 2.25 |
| 36 | 3/31/2029 | 8% | 100,093 | 108,100 | 18.7% | 1.54x | 16.7% | 1.47x | 2.50 |
| 37 | 6/30/2029 | 8% | 103,711 | 112,008 | 18.4% | 1.59x | 16.6% | 1.52x | 2.75 |
| 38 | 9/30/2029 | 8% | 107,502 | 116,102 | 18.2% | 1.65x | 16.5% | 1.57x | 3.00 |
| 39 | 12/31/2029 | 8% | 111,431 | 120,345 | 17.9% | 1.71x | 16.4% | 1.63x | 3.25 |
| 40 | 3/31/2030 | 8% | 115,415 | 124,648 | 17.7% | 1.77x | 16.3% | 1.68x | 3.50 |
| 41 | 6/10/2030 | 8% | 118,670 | 128,164 | 17.6% | 1.82x | 16.3% | 1.73x | 3.70 |
IRR on the loan by exit date
Full call at each date at the Applicable Premium in force, entry at par of the September 30, 2026 accreted balance; the last bar is hold to maturity
Compound's Returns tab, the IRR on the loan for each exit date. Team, Inc. 8-K of March 13, 2025 and Exhibit 10.2; Form 10-Q for the quarter ended September 30, 2026.
The 12/31/2026 and 3/31/2027 calls earn the same 33.7% because the premium doubles between them: a call after March 12, 2027 pays 8% instead of 4%, so the extra quarter adds a quarter of PIK and four points of premium, and the multiple moves from 1.08x to 1.16x. After that, a short hold earns a high IRR on little money, and the multiple only builds with time. The LBO model page shows the same returns arithmetic from the sponsor’s side.
The warrant columns are 1.4 to 3.9 points lower (our arithmetic), because the $6.6 million of warrant value is counted at entry and the base case holds the share price flat at $24.79. Warrants that expire on December 8, 2028 are realized at the first quarter end after expiry, at intrinsic value, $4.9 million.
IRR sensitivity to the exit date and the share price at exit
Held to maturity, the IRR including warrants runs from 14.8% at a share price 60% below the latest close to 18.5% at 60% above. Only an exit at the end of 2026 is exposed: there the range is -1.0% to 78.8%.
| B | C | D | E | F | G | H | I | J | |
|---|---|---|---|---|---|---|---|---|---|
| 7 | Exit date \ share price at exit ($) | $9.92 | $14.87 | $19.83 | $24.79 | $29.75 | $34.71 | $39.66 | IRR, loan only |
| 8 | 12/31/2026 | -1.0% | 6.9% | 17.4% | 30.0% | 44.5% | 60.8% | 78.8% | 33.7% |
| 9 | 12/31/2027 | 14.3% | 15.6% | 17.4% | 19.5% | 21.7% | 24.1% | 26.5% | 22.3% |
| 10 | 12/31/2028 | 14.5% | 14.5% | 15.6% | 16.8% | 18.0% | 19.2% | 20.3% | 19.1% |
| 11 | 12/31/2029 | 14.7% | 14.7% | 15.5% | 16.4% | 17.2% | 18.0% | 18.9% | 17.9% |
| 12 | 6/10/2030 | 14.8% | 14.8% | 15.5% | 16.3% | 17.0% | 17.7% | 18.5% | 17.6% |
The price applies at the exit date, or at warrant expiry for later exits. A three-month hold carries the full $6.6 million of warrant cost against a small loan return, so the stock decides the outcome: at $9.92 the warrants are worth $1.1 million on exit and the position loses money. From 2028 on, the two lowest columns are identical, because the warrants expire below the $15.00 strike and pay nothing.
The 0% column ties to the Returns tab, and the grid is live formulas that trace to the Assumptions sheet. For the method, see sensitivity analysis.
Leverage through the security, coverage and the intercreditor position
Leverage through the second lien is 6.21x last-twelve-month Adjusted EBITDA of $52.6 million, under the 7.0x flag, and 7.80x through the Series B preferred below it. Cash interest coverage is 2.22x, well above 1.5x, but only because the second lien pays in kind; paid in cash it would be 1.58x today and 1.54x at its low point.
| B | C | E | F | G | H | I | J | |
|---|---|---|---|---|---|---|---|---|
| 6 | Rank | Tranche | Amount | Rate | Maturity | Cumulative | Cum. x EBITDA | Cum. net x |
| 7 | Priority 1 | ABL revolver | 73,986 | 7.67% | 10/2/2028 | 73,986 | 1.41x | 1.25x |
| 8 | Priority 2 | Equipment loans and finance leases | 9,823 | 8.00% | 83,809 | 1.59x | 1.44x | |
| 9 | Priority 3 | First lien term loan | 172,375 | 10.00% | 3/12/2030 | 256,184 | 4.87x | 4.71x |
| 10 | Priority 4 | Second lien term loan (the security) | 70,347 | 13.75% | 6/10/2030 | 326,531 | 6.21x | 6.05x |
| 11 | Priority 5 | Series B preferred (stated value) | 84,130 | 10.50% | 12/31/2030 | 410,661 | 7.80x | 7.65x |
| 12 | Priority 6 | Common equity (market value) | 113,618 | 524,279 | 9.96x | 9.81x | ||
| 13 | Total capitalization ($000) | 524,279 | ||||||
| 14 | Less: cash and cash equivalents | (11,010) | ||||||
| 15 | Implied enterprise value ($000) | 513,269 | ||||||
| 16 | Implied EV / LTM Adjusted EBITDA (x) | 9.8x |
Last-twelve-month Adjusted EBITDA is the fourth quarter of 2025, $16.4 million, plus the first nine months of 2026, $36.2 million, on the company’s own definition. The market values the whole capital structure at $513.3 million, 9.8x EBITDA, with the common at $113.6 million.
Under the 2025 Intercreditor Agreements, as the Credit tab describes them, the ABL has first priority on the ABL Priority Collateral and the first lien term loan on substantially all other assets. The second lien has second priority on substantially all assets, behind both, and its mandatory prepayments are “deferred until first lien obligations are discharged.” Both senior facilities mature first: the ABL on October 2, 2028 and the first lien term loan on March 12, 2030, three months before the second lien. As the answer puts it, “a refinancing has to come first.”
Below the second lien sits the Series B preferred, $84.1 million of stated value with its PIK dividends, “junior to all existing and future liabilities”, accreting at 10.5% with a holder put on or after December 31, 2030. It is equity in the waterfall, but it grows faster than EBITDA in the base case, and its put falls about six months after the second lien matures.
| B | E | F | G | |
|---|---|---|---|---|
| 19 | Metric | Value | Threshold | Status |
| 20 | LTM Adjusted EBITDA at 2026-09-30 ($000) | 52,620 | ||
| 21 | Total debt through the security ($000) | 326,531 | ||
| 22 | Leverage through the security (x) | 6.21x | 7.0x | OK |
| 23 | Net leverage through the security (x) | 6.05x | ||
| 24 | Leverage through Series B preferred (x) | 7.80x | ||
| 25 | First Lien Net Leverage, model proxy (x) | 4.53x | ||
| 26 | Covenant maximum First Lien Net Leverage (x) | 6.50x | ||
| 27 | Covenant EBITDA cushion (%) | 30.3% | ||
| 28 | Run-rate cash interest: ABL | 5,675 | ||
| 29 | Run-rate cash interest: first lien term loan | 17,238 | ||
| 30 | Run-rate cash interest: equipment loans and leases | 786 | ||
| 31 | Run-rate cash interest: second lien cash portion | 0 | ||
| 32 | Run-rate cash interest, total ($000) | 23,698 | ||
| 33 | Cash interest coverage (x) | 2.22x | 1.5x | OK |
| 34 | Coverage if the second lien paid fully in cash (x) | 1.58x | 1.5x | OK |
| 35 | (Adj. EBITDA less capex at guidance midpoint) / cash interest (x) | 1.65x | ||
| 36 | Projection: peak leverage through the security (x) | 6.21x | 7.0x | OK |
| 37 | Projection: trough cash interest coverage (x) | 2.22x | 1.5x | OK |
| 38 | Projection: trough coverage if the second lien paid in cash (x) | 1.54x | 1.5x | OK |
Cash interest is the ABL, the first lien term loan at 10.00% and the equipment debt; after capex at the midpoint of guidance, coverage is 1.65x. The PIK toggle is what keeps the coverage flag clear: paid in cash, the second lien would take coverage to 1.58x, just above the threshold.
The covenant allows first lien net leverage of up to 6.50x through the fourth quarter of 2026 and 6.00x after, set by the September 2025 amendment; on the model’s proxy the EBITDA cushion is 30.3%. Peak leverage through the security is the entry figure, 6.21x, because EBITDA steps up to the $56.0 million low end of guidance at the end of 2026; after that accretion and growth roughly offset, and leverage stays between 5.70x and 5.87x until the final quarter. For how covenant tests like this one are built, see covenant compliance calculation.
Downside recovery at a distressed multiple
In the downside, Team defaults on December 31, 2027 with EBITDA 25% below the base case, $44.1 million, valued at 5.0x. After 5% of costs, $209.5 million is left for $280.5 million of senior claims, so the second lien recovers nothing, and the 50% flag trips. It takes 6.7x to reach the second lien’s first dollar and 8.7x to repay it in full.
| B | E | F | G | |
|---|---|---|---|---|
| 41 | Default date | 12/31/2027 | ||
| 42 | Base-case LTM Adjusted EBITDA at default | 58,800 | ||
| 43 | EBITDA haircut | 25% | ||
| 44 | Stressed LTM Adjusted EBITDA | 44,100 | ||
| 45 | Distressed EV / EBITDA multiple (x) | 5.0x | ||
| 46 | Gross enterprise value | 220,500 | ||
| 47 | Less: restructuring and administrative costs | (11,025) | ||
| 48 | Net value available to creditors ($000) | 209,475 | ||
| 49 | ABL claim (drawn at default plus availability drawn) | 100,507 | ||
| 50 | Equipment loans and finance leases claim | 9,823 | ||
| 51 | First lien term loan claim | 170,185 | ||
| 52 | Claims senior to the second lien ($000) | 280,515 | ||
| 53 | Value available to the second lien | 0 | ||
| 54 | Second lien accreted balance at default | 83,776 | ||
| 55 | Second lien claim (accreted, plus premium if included) | 83,776 | ||
| 56 | Second lien recovery ($000) | 0 | ||
| 57 | Second lien recovery, % of accreted balance | 0.0% | 50% | FLAG |
| 58 | Senior claims coverage (x) | 0.75x | ||
| 59 | Value left for Series B preferred and common | 0 | ||
| 60 | Series B stated value at default | 95,787 | ||
| 61 | Series B recovery, % of stated value | 0.0% | ||
| 62 | EV / EBITDA multiple for first dollar of second lien recovery (x) | 6.7x | ||
| 63 | EV / EBITDA multiple for full second lien recovery (x) | 8.7x |
The verdict is harsh, and three assumptions drive it. The 5.0x multiple is set at “about half the current implied EV / LTM EBITDA”, the 9.8x on the Credit tab. The 25% haircut “approximates a deep cyclical downturn” for a business with turnaround-driven revenue. And the ABL claim assumes the company draws 75% of its $35.4 million of availability before it defaults, which lifts the ABL from $74.0 million to $100.5 million. At 5.0x the senior claims are covered only 0.75x, so the first lien itself is short by $71.0 million (our arithmetic) before the second lien’s turn comes.
The default date sits in what the Assumptions sheet calls “the stress window”, after the covenant step-down and before the ABL matures in October 2028, by which time the claim has accreted to $83.8 million. For a full creditor waterfall with deficiency claims and a fulcrum class, see recovery analysis.
| D | E | F | G | H | I | |
|---|---|---|---|---|---|---|
| 66 | EBITDA haircut \ distressed multiple | 5.0x | 6.0x | 7.0x | 8.0x | 9.0x |
| 67 | 5% | 0% | 45% | 100% | 100% | 100% |
| 68 | 15% | 0% | 5% | 62% | 100% | 100% |
| 69 | 25% | 0% | 0% | 15% | 65% | 100% |
| 70 | 35% | 0% | 0% | 0% | 12% | 55% |
| 71 | 45% | 0% | 0% | 0% | 0% | 0% |
The grid shows how binary a second lien behind $280.5 million of senior debt is: at 5.0x it recovers nothing at any haircut. At the 25% haircut it moves from 15% at 7.0x to 65% at 8.0x and 100% at 9.0x. Nine of the 25 cells clear the 50% threshold, and 12 are at zero (our count). Every cell that clears 50% needs a multiple of 7.0x or more, against the 9.8x at which the market values the company today.
What the public filings cannot tell you
The filings give the terms, the balances and the ranking. Whether the loan pays cash, what the premium is worth and what the second lien recovers depend on documents only the company has. Compound’s answer ends with the list.
- Compliance certificates using the agreement’s definitions of EBITDA and first lien net leverage. These set the PIK and cash split, amortization and covenant headroom; the model uses reported Adjusted EBITDA as a proxy.
- The 2025 Intercreditor Agreements: standstill, payment blockage, turnover and DIP terms against the ABL and first lien. The credit agreement analysis page covers that review.
- Confirmation that the 8% premium is due at maturity and on acceleration. This is worth 2.4 points of IRR at maturity and decides whether the downside claim includes it (our arithmetic).
- Pricing grids and the borrowing base for the senior debt, plus the plan to refinance the October 2028 ABL and March 2030 first lien maturities.
- A 2027 budget and a 13-week cash flow, for the timing of the turnaround recovery, the cost program, capex and working capital.
- Terms of the equipment loans, leases, letters of credit and the surety collateral facility.
- The plan for the Series B holder put on or after December 31, 2030, and any use of the $30.0 million preferred delayed draw.
- The Corre warrant agreement and a fully diluted capitalization table, for anti-dilution, net exercise and the share count behind the warrant value.
Our view
The model accretes the loan under the real toggle, prices the call protection at every date, values the equity and shows plainly that the downside leaves nothing for the second lien. We would underwrite to 15.2%, treat the 8% at maturity as upside until counsel confirms it, and spend the diligence on the senior refinancing and the multiple.
The base case is a loan that never pays cash and grows to $118.7 million against EBITDA that reaches $63.8 million. Leverage stays under the flag because EBITDA grows 5% in 2027 and 4% in 2028, and coverage stays clear because the second lien is not paid in cash. The return is mostly time and the premium, and little of the share price.
The other side is that the downside may be conservative. The 5.0x multiple is half where the market prices the company, the ABL claim assumes a run on availability, and a lender that believes the premium survives acceleration would add it to the claim. A holder who thinks a distressed sale of an inspection and heat-treating business clears 7.0x would see a recovery in three of the five haircut rows (our count).
Three things would change our view: compliance certificates that put true first lien leverage near the 3.50x toggle, a refinancing of the senior debt that keeps the second lien’s position intact, and counsel’s reading of the premium trigger. The direct lending underwriting model covers the senior side of a structure like this, and private credit valuation the mark on the loan.
Team, Inc. second lien PIK model (Excel)Compound’s workbook from this run: a Summary with the flags, an Assumptions sheet with a source or reason beside every input, the quarterly Security_CF with PIK accretion, Returns by call date with the warrant value, Credit with the capital structure and downside recovery, the Sensitivity grid, Vol_Calc and Sources.Download · FreeFAQ
How does a leverage-based PIK toggle work?
The borrower’s leverage ratio at each test date sets how much of the coupon is paid in cash and how much is added to principal. In Team’s second lien, interest is all PIK at first lien net leverage of 3.50x or more, half cash between 3.00x and 3.50x, and all cash at 3.00x or less, so the investor’s cash yield rises only as the company delevers.
Is a call premium due at maturity?
Usually not: most call protection is a prepayment premium. The answer turns on how the trigger is defined, and Team’s agreement triggers its Applicable Premium on any payment of principal “for any reason”, which read literally includes maturity. In this model that reading is worth the difference between a 17.6% and a 15.2% IRR.
How do you value warrants attached to mezzanine debt?
Black-Scholes on the share price, strike, time to expiry, a matching risk-free rate and the stock’s volatility is the usual start. Here 500,000 warrants at $15.00 are worth $6.6 million at 58.3% realized volatility; a full valuation also adjusts for dilution from other warrants and the terms of the warrant agreement.
Why does IRR fall and MOIC rise the longer a PIK loan is held?
An early call earns the premium over a short hold, a high annualized rate on a small gain, while a long hold compounds PIK into a larger multiple at a lower rate. Team’s second lien returns 33.7% on 1.08x if called at the end of 2026 and 17.6% on 1.82x at maturity.
Should a second lien recovery claim include the PIK and the make-whole?
The accreted PIK is principal and belongs in the claim. Whether a make-whole or applicable premium is allowed after acceleration is contested in chapter 11, so many recovery models measure on accreted principal, as this one does with an $83.8 million claim at default.





